Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers

American Journal of Cardiology

Volumn 97, Issue 5, 2006, Pages 640-645

  Johnston, Nina ^a   Jernberg, Tomas ^a   Lagerqvist, Bo ^a   Siegbahn, Agneta ^a   Wallentin, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; MULTICENTER STUDIES; PHOSPHOLIPASES A; ROC CURVE; SWEDEN; TRIGLYCERIDES;

EID: 32844458768     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.09.123     Document Type: Article

References (26)

1. P. Holvoet, A. Mertens, P. Verhamme, K. Bogaerts, G. Beyens, R. Verghaeghe, D. Collen, E. Muls, F. Van de Werf Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease Arterioscler Thromb Vasc Biol 21 2001 844 848
2. S. Toshima, A. Hasegawa, M. Kurabayashi, H. Itabe, T. Takano, J. Sugano, K. Shimamura, J. Kimura, I. Michisita, T. Suzuki, R. Nagai Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease Arterioscler Thromb Vasc Biol 20 2000 2243 2247
3. T. Suzuki, H. Kohno, A. Hasegawa, S. Toshima, T. Amaki, M. Kurabayashi, R. Nagai Clinical Trial of Oxidized LDL (CTOL) Investigators Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease Clin Biochem 35 2002 347 353
4. M.J. Caslake, C.J. Packard, K.E. Suckling Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase a potential new risk factor for coronary artery disease Atherosclerosis 150 2000 413 419
5. P. Holvoet, S.B. Kritchevsky, R.P. Tracy The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort Diabetes 53 2004 1068 1073
6. K. Shimada, H. Mokuno, E. Matsunaga Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease Atherosclerosis 174 2004 343 347
7. E.S. Brilakis, J.P. McConnell, R.J. Lennon Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up Eur Heart J 26 2005 137 144
8. H.H. Oei, I.M. van der Meer, A. Hofman, P.J. Koudstaal, T. Stijnen, M.M. Breteler Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke the Rotterdam Study Circulation 111 2005 570 575
9. M. Zweig, G. Campbell Receiver-operating characteristic (ROC) plots a fundamental evaluation tool in clinical medicine Clin Chem 39 1993 561 577
10. N.A. Obuchowski, M.L. Lieber, F.H. Wians Jr ROC curves in clinical chemistry uses, misuses, and possible solutions Clin Chem 50 2004 1118 1125
11. FRISC-2 Investigators Invasive compared with non-invasive treatment in unstable coronary artery disease FRISC II prospective randomised multicentre study Lancet 354 1999 708 715
12. N. Johnston, T. Jernberg, B. Lindahl, J. Lindbäck, M. Stridsberg, A. Larsson, P. Venge, L. Wallentin Biochemical indicators of cardiac and renal function in a healthy elderly population Clin Biochem 37 2004 210 216
13. W.T. Friedewald, R.I. Levy, D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
14. J.A. Swets Measuring the accuracy of diagnostic systems Science 240 1988 1285 1293
15. D. Steinberg, A. Lewis Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis Circulation 95 1997 1062 1071
16. A. Boullier, D.A. Bird, M.K. Chang, E.A. Dennis, P. Friedman, K. Gilottre-Taylor, S. Hörkkö, W. Palinski, O. Quehenberger, P. Shaw, D. Steinberg, V. Terpstra, J.L. Vitzum Scavenger receptors, oxidized LDL, and atherosclerosis Ann NY Acad Sci 947 2001 214 223
17. J.A. Berliner, M. Navab, A.M. Fogelman, L.L. Demer, P.A. Edwards, A. Watson, A.J. Lusis Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics Circulation 91 1995 2488 2496
18. P. Barter, J. Kastelein, A. Nunn, R. Hobbs Future Forum Editorial Board High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions Atherosclerosis 168 2003 195 211
19. W.P. Castelli Cholesterol and lipids in the risk of coronary artery disease - the Framingham Heart Study Can J Cardiol 4 1998 5A 10A
20. A. Mertens, P. Holvoet Oxidized LDL and HDL antagonists in atherothrombosis FASEB J 15 2001 2073 2084
21. N.E. Nielsen, A.G. Olsson, E. Swahn Plasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristics J Intern Med 247 2000 43 52
22. E.T. Bairaktari, K.I. Seferiadis, M.S. Elisaf Evaluation of methods for the measurement of low-density lipoprotein cholesterol J Cardiovasc Pharmacol Ther 1 2005 45 54
23. R.S. Rosenson Myocardial injury. The acute phase response and lipoprotein metabolism J Am Coll Cardiol 22 1993 933 940
24. P. Holvoet, J. Vanhaecke, S. Janssens, F. Van de Werf, D. Collen Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease Circulation 98 1998 1487 1494
25. S. Ehara, M. Ueda, T. Naruko Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes Circulation 103 2001 1955 1960
26. H. Itabe Oxidized low-density lipoproteins what is understood and what remains to be clarified Biol Pharm Bull 26 2003 1 9